Search Results

Prostate cancer: a serious disease suitable for prevention

Authors: Fitzpatrick, John M.; Schulman, Claude; Zlotta, Alexandre R.; Schröder, Fritz H.

Source: BJU International, Volume 103, Number 7, April 2009 , pp. 864-870(7)

Publisher: Blackwell Publishing

Toremifene not for patients with heart problems, says EMEA

Source: Reactions, Volume 1, Number 1237, 2009-01-31 , pp. 3-3(1)

Publisher: Adis International

Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases

Authors: Elkin, Adam; Jacobs, Charlotte

Source: Journal of Cancer Research and Clinical Oncology, Volume 134, Number 10, October 2008 , pp. 1151-1153(3)

Publisher: Springer

Toremifene a strong option in androgen-deprivation therapy

Source: Inpharma, Volume 1, Number 1635, 2008-04-26 , pp. 7-8(2)

Publisher: Adis International

Toremifene gives prostate cancer patients a break

Source: Inpharma, Volume 1, Number 1627, 2008-03-01 , pp. 6-6(1)

Publisher: Adis International

Toremifene may effectively reduce hot flushes among men undergoing androgen deprivation therapy (ADT) for prostate cancer.

Source: Inpharma, Volume 1, Number 1628, 2008-03-08 , pp. 6-6(1)

Publisher: Adis International

Treatment of bicalutamide-induced breast events

Author: Sieber, Paul R

Source: Expert Review of Anticancer Therapy, Volume 7, Number 12, December 2007 , pp. 1773-1779(7)

Publisher: Expert Reviews

Atamestane + toremifene vs letrozole in breast cancer

Source: Inpharma, Volume 1, Number 1616, 2007-12-01 , pp. 20-20(1)

Publisher: Adis International

Estrogen Receptor Modulators and Down Regulators: Optimal Use in Postmenopausal Women With Breast Cancer

Authors: Baumann, Christa K.; Castiglione-Gertsch, Monica

Source: Drugs, Volume 67, Number 16, 2007 , pp. 2335-2353(19)

Publisher: Adis International

The effects of atamestane and toremifene alone and in combination compared with letrozole on bone, serum lipids and the uterus in an ovariectomized rat model

Authors: Goss, Paul; Qi, Shangle; Hu, Haiqing; Cheung, Angela

Source: Breast Cancer Research and Treatment, Volume 103, Number 3, July 2007 , pp. 293-302(10)

Publisher: Springer

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development

Authors: Gennari, Luigi; Merlotti, Daniela; Valleggi, Fabrizio; Martini, Giuseppe; Nuti, Ranuccio

Source: Drugs & Aging, Volume 24, Number 5, 2007 , pp. 361-379(19)

Publisher: Adis International

Medicinal Chemistry and Emerging Strategies Applied to the Development of Selective Estrogen Receptor Modulators (SERMs)

Authors: Musa, Musiliyu A.; Omar F. Khan, M.; Cooperwood, John S.

Source: Current Medicinal Chemistry, Volume 14, Number 11, May 2007 , pp. 1249-1261(13)

Publisher: Bentham Science Publishers

Flexible Estrogen Receptor Modulators: Synthesis, Biochemistry and Molecular Modeling Studies for 3-Benzyl-4,6-diarylhex-3-ene and 3,4,6-Triarylhex-3-ene Derivatives

Authors: Smith, Helena M.; S. Knox, Andrew J.; Zisterer, Daniela M.; Lloyd, David G.; Meegan, Mary J.

Source: Medicinal Chemistry, Volume 3, Number 2, March 2007 , pp. 135-155(21)

Publisher: Bentham Science Publishers

Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)

Authors: Perey, L; Paridaens, R; Hawle, H; Zaman, K; Nolé, F; Wildiers, H; Fiche, M; Dietrich, D; Clément, P; Köberle, D; Goldhirsch, A; Thürlimann, B

Source: Annals of Oncology, Volume 18, Number 1, January 2007 , pp. 64-69(6)

Publisher: Oxford University Press

The Cardiovascular Effects of Selective Estrogen Receptor Modulators

Authors: CHRISTODOULAKOS, G.E.; LAMBRINOUDAKI, I.V.; BOTSIS, D.C.

Source: Annals of the New York Academy of Sciences, Volume 1092, Number 1, December 2006 , pp. 374-384(11)

Publisher: Blackwell Publishing

Toremifene reduces premenstrual breast pain

Source: Inpharma, Volume 1, Number 1548, 2006-07-29 , pp. 9-9(1)

Publisher: Adis International

Toremifene lowers total cholesterol and raises HDL-cholesterol in patients with advanced prostate cancer

Source: Inpharma, Volume 1, Number 1544, 2006-07-01 , pp. 18-18(1)

Publisher: Adis International

Toremifene for premenstrual mastalgia: a randomised, placebo-controlled crossover study

Authors: Oksa; Luukkaala; Mäenpää

Source: BJOG: An International Journal of Obstetrics & Gynaecology, Volume 113, Number 6, June 2006 , pp. 713-718(6)

Publisher: Blackwell Publishing

DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver

Authors: Hashiba, Masamichi; Kasahara, Toshihiko; Kim, Sung Yeon; Shibutani, Shinya; Degawa, Masakuni

Source: Cancer Science, Volume 97, Number 6, June 2006 , pp. 468-477(10)

Publisher: Blackwell Publishing

Toremifene – a promising therapy for the prevention of prostate cancer and complications of androgen deprivation therapy

Authors: Taneja, Samir S; Smith, Matthew R; Dalton, James T; Raghow, Sharan; Barnette, Gary; Steiner, Mitchell; Veverka, Karen A

Source: Expert Opinion on Investigational Drugs, Volume 15, Number 3, 1 March 2006 , pp. 293-305(13)

Publisher: Informa Healthcare